Evaluation of the Accuracy of Immunostaining of Claudin 2 to Detect Active or Inactive Inflammation in Endoscopic Biopsies of IBD
Recruiting now
Conditions studied: Ulcerative Colitis (UC), Crohn Disease
In brief
In view of the increasing evidence of the importance of mucosal healing as a combination of endoscopic and histologic healing, and the complexity and lack of complete agreement of the evaluation of histologic healing in IBD, the aim of this study will be to evaluate the accuracy of a new methodology, the immunostaining for Claudine 2 as compared to others standard well-accepted scoring for histologic activity in IBD. The aim is compare the accuracy of this methodology and in addition the correlation with outcomes (i.e. relapse, hospitalization, surgery).
Key facts
- Study ID
- NCT07710287
- Run by
- IRCCS Policlinico S. Donato
- People needed
- 100
- Starts
- 2025-02-14
- Expected to finish
- 2027-09-01
- Last updated by the study team
- 2026-07-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Confirmed diagnosis of IBD
You may not qualify if…
- Unconfirmed diagnosis of IBD
Where it is running
- Gastroenterology IRCCS San Donato Policlinic — San Donato Milanese, Mi, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.